bioRxiv Science⌕ Search

Biology subjects

Sarazin, C.

Publications and source records attributed to Sarazin, C..

2 recordsLinked to original sources

Sphingolipid-driven interleaflet coupling orchestrates Rho-GTPase recruitment to nanodomains for signal activation in plants

Biological membranes are both laterally heterogeneous and asymmetrical across leaflets, yet how this asymmetry contributes to signal transduction remains unclear. Here we show that sphingolipid-driven interleaflet coupling coordinates nanodomain organization and Rho-GTPase activation in plants. Using molecular dynamics simulations, super-resolution and single-molecule imaging, quantitative genetics, and biochemistry, we find that very long acyl chain (VLCFA)-containing sphingolipids in the outer leaflet interdigitate with phosphatidylserine (PS) in the inner leaflet, forming a vertical molecular bridge that organizes PS into nanodomains. This coupling promotes recruitment and activation of the Rho-GTPase ROP6 in response to auxin, whereas disruption of VLCFA synthesis or sphingolipid composition disperses PS and ROP6 nanodomains, impairing cytoskeletal reorganization and directional growth. Our findings reveal interleaflet coupling as a fundamental organizing principle linking membrane asymmetry to signaling, providing a conceptual framework for spatial and temporal control of signal transduction across eukaryotic membranes.

plant biology↗

Lipid nanoemulsion incorporating DOTAP reverse micelles as clinically translatable carriers of ALDH inhibitors for lung cancer therapy

Lung cancer remains the most prevalent malignancy worldwide and the leading cause of cancer-related deaths. In this study, we designed and optimized a lipid nanosystem incorporating the cationic lipid DOTAP by utilizing reverse micelle structures to enhance pulmonary tropism. Fluorescence quenching assays confirmed the incorporation of reverse micelles into the oily core, thus validating the structural integrity of the system. This nanosystem was tailored for the encapsulation of ABD0171, a potent inhibitor of ALDH1A3, an enzyme strongly associated with chemoresistance in lung cancer. Physicochemical characterization revealed robust colloidal properties with a particle diameter of 60 nm, a surface charge of +45 mV, and a drug encapsulation yield of 99%. In vitro, formulations with/without DOTAP demonstrated high efficacy against epithelial-like H358 cells derived from human bronchioalveolar carcinoma, with IC50 values < 5 {micro}M. Chicken ChorioAllantoic Membrane (CAM) evaluations demonstrated good tolerability of the DOTAP-containing formulation and significant H358 tumor reduction by 28% compared with the untreated control, while maintaining a favorable safety profile. By combining industrially feasible methods with FDA-approved components, this study demonstrated the potential of DOTAP-containing lipid nanosystems as scalable platforms for the delivery of ALDH inhibitors for lung cancer treatment. These findings provide a pathway for future applications in cancer therapy, bridging the gap between nanosystem innovation and clinical translation. O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=134 SRC="FIGDIR/small/659868v2_ufig1.gif" ALT="Figure 1"> View larger version (29K): org.highwire.dtl.DTLVardef@dbc8org.highwire.dtl.DTLVardef@5d5187org.highwire.dtl.DTLVardef@9391f3org.highwire.dtl.DTLVardef@52fd54_HPS_FORMAT_FIGEXP M_FIG Graphical abstract C_FIG

bioengineering↗